Xianju Pharmaceutical Company: The company's acetate dexamethasone tablets have passed the generic drug consistency evaluation.

On August 22, Xianju Pharmaceutical announced that the company recently received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration for the acetate dexamethasone tablets. The company's acetate dexamethasone tablets have passed the evaluation of generic drug quality and efficacy consistency. Acetate dexamethasone tablets are a type of corticosteroid drug, mainly used for allergic and autoimmune inflammatory diseases. Such as connective tissue diseases, severe bronchial asthma, dermatitis and other allergic diseases, ulcerative colitis, acute leukemia, lymphoma, etc.